Jason Rhodes
Partner · Atlas Venture
Partner
Jason Rhodes is a Partner at Atlas Venture since 2014, focused on creation and business strategy of novel therapeutics companies. He was founding CEO and chairman of Generation Bio and Dyne Therapeutics, and founding CEO of Disarm Therapeutics, acquired by Eli Lilly. He previously served as president of Epizyme.
Board seats
77 current
· PUBLIC SOURCES
Credited hits
4
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Jason Rhodes, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Disarm Therapeuticsacquired
Atlas-backed company he worked with that was acquired by Eli Lilly, per his Atlas bio.
Source: atlasventure.com
- Mithrilacquired
Atlas-backed company he worked with that was acquired by Anthropic, per his Atlas bio.
Source: atlasventure.com
- Gemini Therapeuticsacquired
Acquired by Disc Medicine in December 2022; Rhodes served on its board 2016 until acquisition, per Generation Bio proxy.
Source: sec.gov
- Dyne Therapeuticsipo
Rhodes was founding CEO and chairman; NASDAQ DYN, per K36 bio.
Source: k36tx.com
Board seats
Current board seats · 7
- Accent TherapeuticsSource: atlasventure.com
- KaryoVerseSource: atlasventure.com
- AAVantgarde BioSource: atlasventure.com
- WeaverSource: atlasventure.com
- Dyne TherapeuticsSource: sec.gov
- Rectify PharmaceuticalsSource: sec.gov
- K36 TherapeuticsSource: k36tx.com
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- atlasventure.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Jason Rhodes. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Jason Rhodes.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Jason Rhodes — provenance: GlassVC extended catalog, November 2026
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
